Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

Conditions

• Peripheral Arterial Disease

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Study Details

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data available since Jan 1 2005 will be included in the registry, until 14,000 patients have been included. The primary objectives of this observational registry study are to: 1. Compare stent and non-stent based outcomes defined as a composite of symptom driven target vessel revascularization (TVR), unplanned surgical revascularization of the target limb and need for target limb amputation through 12 months post-index procedure (Primary efficacy endpoint) 2. Compare stent and non-stent based outcomes defined as a composite of causes such as: death, myocardial infarction (MI), stroke, peri-procedural complications, target vessel revascularization (TVR) and unplanned surgical revascularization/amputation of the target limb through 12 months (Primary safety endpoint) 3. Compare stent and non-stent based change in walking distance, Rutherford category and/or ankle- brachial index (ABI) at 12 months compared to baseline (Primary clinical improvement endpoint) Approximately 14,000patients will be enrolled at approximately 60 sites worldwide. Enrollment in the observational study will be monitored in an effort to achieve at least 20% (and no more than 80%) of the population receiving stents as the initial treatment strategy. Follow-up visits by sites will be reported at 6 and 12 months after index procedure to collect data on treatment patterns and effectiveness, and outcomes. The follow-up procedures are not mandated by the registry protocol. Each site will be encouraged to enter follow-up information derived from clinically indicated follow-up visits. All events post-index procedure till the 7th month will be reported under the 6 month follow-up form and subsequent follow-up till the 13th month post-procedure will be entered on the 12 month follow-up form. Patient management and treatment decisions are at the discretion of the care team per routine clinical practice. The procedural aspects (including selection of stent type or non-stent based treatments) and follow-up are not mandated by the registry and will be up to the discretion of the operator and/or based upon the practice dictated by the clinical care of the patient. Therefore the study poses minimal risk to the patient.

Key Dates

Start date

Jan 31, 2013

Status verified

Sep 2025

Primary completion

Jan 31, 2033

Completion

Jan 31, 2033

Study Design

Enrollment

14,000 participants (estimated)

Arms

• Arm: Stent
  The patient received one or more stents to the superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries in AT LEAST one of the lesions treated during the course of the procedure.
• Arm: Non-Stent
  The patient did not receive a stent to the superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries in ANY of the lesions treated during the course of the procedure.

Primary Outcome Measure

Target Limb Revascularization [ Time Frame: 12 months ]

Central Contacts

• David Fernandez Vazquez, MD
  2148202928
  [email protected]

Locations (24)

Find similar trials in Little Rock, AR

Related Studies

• A Real-World Registry of Chronic Wounds and Ulcers
  Recruiting · U.S. Wound Registry · The Woodlands, Texas
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
  PHASE3 · Recruiting · Population Health Research Institute · New Haven, Connecticut
• Assessment of the Utility of the Pantheris Small Vessel (SV) System
  Recruiting · Avinger, Inc. · Grand Rapids, Michigan
• SELUTION4BTK Trial
  Recruiting · M.A. Med Alliance S.A. · Chandler, Arizona